TINIES for BBVs_V1.0

  • Research type

    Research Study

  • Full title

    Small Volume Blood Testing Validity and Acceptability for HIV-1 and/or Hepatitis B

  • IRAS ID

    320422

  • Contact name

    Stuart Flanagan

  • Contact email

    stuart.flanagan@nhs.net

  • Sponsor organisation

    Noclor on behalf on Central and North West London NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    NCT05690607

  • Duration of Study in the UK

    1 years, 0 months, 0 days

  • Research summary

    This study aims to answer two questions: 1) Is it possible to accurately measure Human Immunodeficiency Virus (HIV) and hepatitis B virus (HBV) viral load using finger prick small volume blood sampling (TINIES) and 2) do people living with HIV and HBV find home testing with small volume finger prick blood samples (TINIES) acceptable? The main benefit of using TINIES self-testing is that it gives the person living with HIV or HBV, the option to do their blood tests at home and have a telephone clinic appointment. This minimises unnecessary trips to the hospital, which may be more convenient for people living with HIV or HBV, and may reduce burden on phlebotomy services. Adults, living with HBV or HIV who attend Mortimer Market Centre for their care are eligible for this study. It will be a single site study, aiming to collect all data aver 6-12 months. There are two phases. In the first phase, participants attending for their routine blood test appointment will be offered an additional finger prick blood test to collect and additional viral load, renal and liver function blood test. These will be compared with the venepuncture blood sample to validate TINIES sampling. In the second phase, people attending clinic will be asked if they consent to having a TINIES self-testing kit sent to their home. They will be asked to complete an online questionnaire, and a small cohort a telephone interview, to ascertain their views on this method of blood sampling.

  • REC name

    HSC REC A

  • REC reference

    22/NI/0179

  • Date of REC Opinion

    16 Jan 2023

  • REC opinion

    Further Information Favourable Opinion